Complex Physical Therapy Plus Pressotherapy Versus Kinesio Taping in Breast Cancer-Related Lymphedema. Randomized Crossover Trial.
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Violeta Pajero Otero
- Enrollment
- 43
- Locations
- 1
- Primary Endpoint
- Changes in the volume difference between the upper limb with lymphedema and the healthy upper limb before and after treatment.
Overview
Brief Summary
This crossover study compares two different treatment techniques for Breast Cancer-Related Lymphedema: 1. Complex Physical Therapy plus Pressotherapy.
- Kinesio Taping.
Detailed Description
Breast Cancer-Related Lymphedema (BCRL) tends to progress in stage and grade if it is not treated.
Complex Physical Therapy (CPT), that includes Manual Lymph Drainage + Multilayer Bandage + Self-care, is the most used technique in order to join the benefits of each technique by the lack of great results with only one technique. The most volume reduction found in a study was achieved combining CPT and Pressotherapy(P). On the other hand, the use of Kinesio Taping (KT) for BCRL has been spreading lately although its clinical efficacy has not been determined by high quality studies.
GOALS:
Main objective: To analyze the effectiveness in the reduction of BCRL volume with KT versus CPT+P in patients attended at the rehabilitation service at HU12Octubre.
Secondary objectives:
To analyze possible changes after each therapy in:
- DASH (Disability Arm, Shoulder and Hand) outcome measure score.
- TTDL (textile therapeutic device for lymphedema) questionnaire score (a quality of life questionnaire for patients with breast cancer-related upper lymb lymphedema using textile therapeutic device that has been validated previously).
- Symptoms associated with BCRL (pain, heaviness, pressure and hardness) using visual analogue scale (VAS).
- Goniometry of Upper Limb.
METHODOLOGY OF THE STUDY:
Design: crossover trial, with a 3-month washout period between both treatment phases. Open design: it is impossible during the treatment to blind physiotherapists and patients, due to the observable differences between both therapies neither during their application nor in the hours after their removal, by the marks left in the skin. The statistical analysis will be supervised by staff of the Clinical Research Unit-Clinical Trials (i+12) of HU12Octubre with the variables coded to blind the analyst.
Interventions: The two therapies compared are:
- CPT+ P.
- KT. Sample size: a sample of 50 patients (25 in each group) was calculated. Subjects of study and randomization: An initial computerized randomized sample was generated among the patients who had attended the Breast Pathology Rehabilitation visit at HU12Octubre during the previous year and who met the eligibility criteria and they were randomly assigned to the groups.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Masking Description
The statistical analysis will be supervised by staff of the Scientific Support Unit: Epidemiology and Biostatistics (i+12), Hospital Universitario 12 de Octubre with the variables coded to blind the analyst.
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Submit BCRL
- •Be a patient of the Breast Pathology Rehabilitation at Hospital Universitario 12 de Octubre.
- •Signing the informed consent.
Exclusion Criteria
- •Breast Cancer metastasis or other active tumor. 2) Intravenous chemotherapy or radiotherapy actually. 3) Heart or kidney failure. 4) Use diuretics. 5) active infection (erysipelas) or any cutaneous disease in UL or back. 5) Bilateral lymphadenectomy. 6) present deterioration or cognitive delay that would prevent understanding instructions and purpose of the study.
- •Have performed treatment for BCRL during the 3 months prior to the start of the study (previous washing phase).
Outcomes
Primary Outcomes
Changes in the volume difference between the upper limb with lymphedema and the healthy upper limb before and after treatment.
Time Frame: Four weeks during each treatment phase
Truncated Cone Formula for Volume from upper limb circumference.
Secondary Outcomes
- Score of the TTDL questionnaire.(Four weeks during each treatment phase)
- Goniometry of Upper Limb.(Four weeks during each treatment phase)
- Symptoms associated with BCRL (pain, heaviness, pressure and hardness) using modified visual analogue scale (VAS).(Four weeks during each treatment phase)
- Body Mass Index.(Four weeks during each treatment phase)
- Score on the DASH Outcome Measure.(Four weeks during each treatment phase)
- Stage of the lymphedema.(Four weeks during each treatment phase)
Investigators
Violeta Pajero Otero
Physiotherapist at the Mammary Pathology Unit
Hospital Universitario 12 de Octubre